• All
  • Important
  • Financial Update
  • Fund Raise
  • Board Meeting
  • Dividend/Bonus
  • JV/Acquisition
  • Investor Meet
  • Insider Trade
  • Pledging
  • Others
    ALPHA TRIBE

    Sun Pharmaceutical Industries Limited — Board Meeting, 31-01-2026: Outcome of Board Meeting

    31-01-2026 | 02:28 pm

    Sun Pharma's Board approved Q3 & 9m FY26 consolidated results. Sales hit ₹15,469 Cr (up 15.1% YoY) with Net Profit at ₹3,369 Cr (up 16.0% YoY). An interim dividend of ₹11/share was declared. Growth seen across India & Innovative Medicines. #SunPharma #Q3Results

    No comments yet. Be the first to comment!

    All announcements from Sun Pharmaceutical Industries Limited